Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Awake during breast cancer surgery? new study tests pain levels

NCT ID NCT06335108

Symptom relief Sponsor: University Hospital Tuebingen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether using a special numbing technique (tumescent local anesthesia) during breast cancer surgery leads to less pain afterward compared to standard general anesthesia. 349 women who had breast cancer surgery took part. The goal was to see if this approach could reduce pain and improve recovery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

349 people

The number who actually took part.

Started

Dec 2022

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population comprises patients presenting with invasive breast carcinoma or pure ductal carcinoma in situ with an indication for surgical treatment at the Department of Women's Health in Tübingen.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥18 years * Written informed consent * Histologically confirmed breast carcinoma or pure ductal carcinoma in situ * Planned operation: * Segmental resection/ breast-conserving surgery * Segmental resection/ breast-conserving surgery with SNB * Ablatio * Ablatio with SNB/ axilla exploration Exclusion Criteria: * Expected lack of patient compliance or inability of the patient to understand the purpose of the study * Lack of patient consent * Pregnancy * Complete axillary dissection * Tumour-adapted reduction surgery, implant reconstructions * Surgeries where technical difficulties are expected under any anaesthesia (e.g. ASA IV, BMI \> 40) * Bilateral breast operations * Men Exclusion Criteria for surgery in TLA: * Injection phobia * Psychoses/ previous psychological illnesses * Advanced dementia * Language barrier

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast carcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast carcinoma breast carcinoma in situ breast neoplasm ductal breast carcinoma in situ

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast carcinoma Breast carcinoma in situ

Contacts and locations

Locations

  • University Women's Hospital

    Tübingen, 72076, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.